Dr. Salman Faruqi is a radiation oncologist at the Arthur J.E. Child Comprehensive Cancer Centre and Clinical Assistant Professor in the Department of Oncology, University of Calgary. He completed his radiation oncology residency at the University of Toronto and a fellowship in intracranial stereotactic radiosurgery and spine SBRT at Sunnybrook Health Sciences Centre, and is certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Radiology. His clinical practice focuses on CNS and cutaneous malignancies, with expertise in radiosurgery and spine SBRT. He serves as Cutaneous Oncology Site Lead and Magnetic Resonance Medical Director (MRMD) at the Arthur Child, and chaired the Provincial CNS Tumour Team for Alberta (2022-2026).
Faruqi, M. Salman
Radiation Oncology
Clinical Assistant Professor
Web Presence:
Biography
Area of Focus
Central nervous system (CNS) malignancies, stereotactic radiosurgery and spine SBRT, cutaneous oncology, and palliative radiotherapy.
Summary of Research
My research focuses on stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), with particular interests in brain metastases, spine SBRT, and radiotherapy for cutaneous malignancies. I am involved in investigator-initiated and cooperative group clinical trials in these areas, and contribute to teaching at the undergraduate, postgraduate, and fellowship levels, including national radiation oncology preparatory courses.
Key publications:
- Faruqi S, Chen H, Fariselli L, et al. Stereotactic Radiosurgery for Postoperative Spine Malignancy: A Systematic Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines. Pract Radiat Oncol. 2022;12(2):e65-e78.
- Faruqi S, Ruschin M, Soliman H, et al. Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases. Int J Radiat Oncol Biol Phys. 2020;106(4):772-779.
- Faruqi S, Tseng CL, Whyne C, et al. Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk Factors. Neurosurgery. 2018;83(3):314-322.
- Faruqi S, Zhang B, Sahgal A. Spinal SBRT for Spine Metastases. In: Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: A Comprehensive Guide, 2nd ed. 2025.
- Das S, Faruqi S, Nordal R, et al. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases. BMC Cancer. 2022;22(1):1368.
Area Of Focus
Central nervous system (CNS) malignancies, stereotactic radiosurgery and spine SBRT, cutaneous oncology, and palliative radiotherapy.
Summary Of Research
My research focuses on stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), with particular interests in brain metastases, spine SBRT, and radiotherapy for cutaneous malignancies. I am involved in investigator-initiated and cooperative group clinical trials in these areas, and contribute to teaching at the undergraduate, postgraduate, and fellowship levels, including national radiation oncology preparatory courses.
Key publications:
- Faruqi S, Chen H, Fariselli L, et al. Stereotactic Radiosurgery for Postoperative Spine Malignancy: A Systematic Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines. Pract Radiat Oncol. 2022;12(2):e65-e78.
- Faruqi S, Ruschin M, Soliman H, et al. Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases. Int J Radiat Oncol Biol Phys. 2020;106(4):772-779.
- Faruqi S, Tseng CL, Whyne C, et al. Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk Factors. Neurosurgery. 2018;83(3):314-322.
- Faruqi S, Zhang B, Sahgal A. Spinal SBRT for Spine Metastases. In: Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: A Comprehensive Guide, 2nd ed. 2025.
- Das S, Faruqi S, Nordal R, et al. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases. BMC Cancer. 2022;22(1):1368.